BioSpace News Archive

The Pink Fund, a non-profit organization that provides financial assistance to breast cancer patients, has announced their 2021 applications are open and the organization plans to distribute $250,000 to qualifying breast cancer patients throughout Michigan.

ImmunityBio, Inc. ( NASDAQ: IBRX ), a clinical-stage immunotherapy company, today announced that Founder and Executive Chairman Dr. Patrick Soon-Shiong will deliver a company presentation at the 2021 Jefferies Virtual Healthcare Conference, which is being held June 1-4, 2021.

ATI Physical Therapy (ATI), one of the nation’s largest providers of physical therapy services, today announced that Labeed Diab , CEO, and Joe Jordan , CFO, will participate in the following upcoming investor conferences:

electroCore’s nVNS device transformed the field of headache therapy and seeks to revolutionize other treatment areas like COVID-19 associated migraine, post-traumatic headache, stroke, Parkinson’s disease and other neurological, and inflammatory conditions

BioStem Technologies, Inc. (OTC PINK: BSEM) (“BioStem” or the “Company”), a leading life sciences company specializing in perinatal tissue allografts for use in regenerative therapies, today announced that it has filed its first quarter financial reports for 2021.

Each Warrant entitles the holder to purchase one common share at an exercise price of CDN$0.93 for a term of four years.

The offering is expected to close on May 26, 2021, subject to satisfaction of customary closing conditions.

Children’s Hospital of Philadelphia announces a collaboration to help children cope with grief and violence, as part of the Healthier Together Initiative.

Gritstone bio, Inc. announced that the Compensation Committee of the company’s Board of Directors has granted five employees nonqualified stock options to purchase an aggregate of 82,200 shares of its common stock, as an inducement material to each of the new employees becoming an employee of Gritstone, in accordance with Nasdaq Listing Rule 5635.

Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its participation in the William Blair 41st Annual Growth Stock Conference which takes place June 1-3, 2021. Ron Rocca, Exagen’s President and Chief Executive Officer, and Kamal Adawi, Chief Financial Officer, will participate in a virtual fireside chat on Wednesday, June 2 at 11:20 AM EDT.